Bronden A, Christensen MB, Glintborg D, Snorgaard O, et al. Effects of DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors, and sulfonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: a network meta-analyses-driven approach. Diabet Med 2023 May 30:e15157. doi: 10.1111/dme.15157.
PMID: 37249579